Skip to content
Clinical ResearchResearch compound

NMN (Nikotinamid‑mononukleotid)

Supplement marketed for anti-ageing that raises NAD+ levels; in one study it improved muscle insulin sensitivity.

Nootropic
Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

NMN (Nikotinamid-mononukleotid) vial

Pharmacology

Half-lifeNMN is rapidly metabolised with a short plasma half-life on the scale of minutes to hours. The rise in NAD+ outlasts this, so once-daily dosing is customary.
OnsetBlood NAD+ rises within days. Trials needed 8-12 weeks for changes measured at clinical endpoints.

Contents

DETAILED OVERVIEW

What is NMN (Nikotinamid-mononukleotid)?

NMN (nicotinamide mononucleotide) is the direct starting material for NAD+ and is also sold as a dietary supplement. NAD+ is a helper molecule involved in the cells' energy production and DNA repair, and its level falls with age; NMN is meant to offset that decline.

Only a few small studies have been done in humans so far. In the strongest one, muscle insulin sensitivity improved in overweight women with prediabetes, while body composition, blood pressure and liver fat did not change. No study has shown that it extends lifespan or reverses ageing. It was well tolerated and may cause mild digestive complaints, but there are no data on use over many years. In cancer it carries a theoretical risk, because NAD+ also plays a role in cell division; there are no safety data for pregnancy or breastfeeding. In 2022 the US FDA took the position that NMN cannot be sold as a dietary supplement in the United States; this is a regulatory classification, not a safety finding.

What it is

The direct biosynthetic precursor of the coenzyme NAD+.

Strongest evidence

In one trial, muscle insulin sensitivity improved in prediabetic women

What it did NOT show

In the same trial, body composition, blood pressure and liver fat were unchanged.

Safety

Well tolerated in the studied range; the longest trials run a few months.

Legal status

Per the FDA's 2022 position it cannot be sold as a dietary supplement in the US.

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Generally well tolerated: the Song 2023 safety review found no serious compound-related adverse effects in human trials within the studied dose range.
  • Mild gastrointestinal complaints: nausea, bloating and occasionally diarrhea, typically at higher doses.
  • Sleep disturbance and alertness: some report an energising effect that can interfere with falling asleep if taken in the evening.
  • Unknown long-term effect: the longest human trials run for a few months. There are no data on years of use, a meaningful limitation for a compound intended as an anti-ageing agent.

Contraindications · 3

  • Active or treated malignancy: NAD+ is a central coenzyme of cell division and DNA repair, so raising it carries a theoretical risk in cancer. Avoid without oncology consultation.
  • Pregnancy and breastfeeding: no safety data.
  • Childhood: the trials were conducted in adults and there are no paediatric data.

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Supplement marketed for anti-ageing that raises NAD+ levels; in one study it improved muscle insulin sensitivity.

Telegram

Have a question about NMN (Nikotinamid‑mononukleotid)?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.